Evidence-Based Pet Nutrition Market Forecasts to 2034 - Global Analysis By Product Type, Pet Type, Health Focus, Distribution Channel, and By Geography

According to Stratistics MRC, the Global Evidence-Based Pet Nutrition Market is accounted for $127.2 billion in 2026 and is expected to reach $202.7 billion by 2034 growing at a CAGR of 6.0% during the forecast period. Evidence-based pet nutrition comprises pet food, therapeutic diets, functional foods, and nutritional supplements developed using scientific research, nutritional assessment, and veterinary guidance to support animal health and well-being. The market encompasses therapeutic and prescription diets, life-stage and breed-specific nutrition, functional foods and supplements, and standard complete nutrition. Products are designed for dogs, cats, and other companion animals, addressing digestive health, renal and urinary health, weight management, joint health, and skin and allergy support. Distribution takes place through veterinary clinics, pet specialty retailers, online platforms, and other retail channels. Growing awareness of preventive animal healthcare, increasing demand for specialized nutrition, and greater emphasis on scientifically supported formulations are driving market development.

Market Dynamics:

Driver:

Increasing focus on preventive pet healthcare and scientifically supported nutrition

Growing awareness of the relationship between nutrition and animal health is a major driver of the evidence-based pet nutrition market. Pet owners increasingly seek food and nutritional products that support digestion, healthy weight, mobility, skin condition, and age-related needs. Veterinary professionals also play an important role in recommending therapeutic diets and nutrition plans for animals with specific health conditions. Manufacturers are investing in research, formulation development, nutritional testing, and product innovation to strengthen the scientific basis of their offerings. Moreover, the humanization of pets and increasing expenditure on companion animal well-being are encouraging demand for specialized nutrition products designed to support long-term health.

Restraint:

High prices and limited affordability of specialized nutritional products

The comparatively high cost of therapeutic diets, veterinary-recommended nutrition, and premium functional products can restrict adoption among price-sensitive consumers. Specialized formulations may require targeted ingredients, scientific research, quality assurance, and additional product development expenditure, which can increase retail prices. Pet owners managing multiple animals or requiring long-term dietary support may face substantial recurring costs. In addition, access to veterinary nutrition guidance can vary across regions, particularly where veterinary services and specialized pet food distribution remain limited. Price sensitivity and differences in consumer awareness may therefore encourage some households to choose conventional pet food instead of specialized products, limiting market penetration in lower-income segments.

Opportunity:

Advancements in personalized nutrition and functional pet food formulations

Advances in animal nutrition research, veterinary diagnostics, and functional ingredients are creating opportunities for specialized and personalized pet nutrition. Manufacturers are developing formulations targeting digestive health, weight control, mobility, urinary health, skin sensitivity, and age-related nutritional requirements. Prebiotics, probiotics, postbiotics, selected proteins, and other functional ingredients are increasingly incorporated into products designed for specific nutritional objectives. Digital veterinary services and online distribution can also improve access to specialized diets and recurring product purchases. Furthermore, research collaborations between nutrition companies, veterinary professionals, and scientific institutions can support evidence-based product development and strengthen consumer confidence in differentiated nutritional solutions.

Threat:

Regulatory scrutiny and competition from conventional pet food and alternative nutrition products

The market faces challenges from regulatory requirements, substantiation of health-related claims, and competition among established pet food manufacturers and emerging specialized brands. Products positioned around particular health benefits must maintain appropriate nutritional quality and comply with applicable feed and labeling requirements. Unsupported claims regarding disease prevention or treatment can expose companies to regulatory action and reputational damage. Conventional complete pet foods, homemade diets, and alternative feeding approaches also compete for consumer spending. Inconsistent scientific evidence, misleading marketing, and differences in product quality can undermine consumer confidence. Companies must therefore balance innovation with nutritional safety, transparent labeling, and credible scientific support.

Covid-19 Impact:

The COVID-19 pandemic influenced the pet nutrition market through changing pet ownership patterns, increased time spent at home, and shifts in purchasing behavior. Greater attention to companion animal care encouraged some consumers to invest in premium pet food, supplements, and products addressing specific nutritional needs. At the same time, manufacturing interruptions, transportation constraints, and temporary retail disruptions affected product availability and supply chains. Veterinary service interruptions also influenced access to professional dietary recommendations in some markets. Following the pandemic, continued interest in pet well-being, online purchasing, and preventive healthcare has supported opportunities for specialized nutrition. Demand continues to be influenced by household spending, veterinary access, and awareness of evidence-based feeding practices.

The Therapeutic and Prescription Diets segment is expected to account for the largest share during the forecast period

The Therapeutic and Prescription Diets segment is expected to hold a leading position in the evidence-based pet nutrition market, supported by demand for specialized dietary management of diagnosed health conditions. Veterinary therapeutic diets are formulated to address nutritional requirements associated with conditions such as kidney disease, digestive disorders, food sensitivities, urinary problems, and weight-related concerns. Veterinary recommendations and established product portfolios from major pet nutrition companies support the adoption of these diets. In addition, increasing awareness of the role of nutrition in managing chronic conditions is encouraging pet owners to consider specialized formulations as part of veterinary-directed care. The segment benefits from its clinical orientation and the recurring nature of dietary management for animals requiring long-term nutritional support.

The Functional Foods and Supplements segment is expected to witness strong growth during the forecast period

The Functional Foods and Supplements segment is expected to experience strong growth as pet owners increasingly seek products designed to support specific health and wellness objectives. Products containing probiotics, prebiotics, omega fatty acids, vitamins, minerals, and joint-support ingredients are marketed for digestive function, skin and coat condition, mobility, and other nutritional needs. Growing interest in preventive care and healthy aging is encouraging manufacturers to develop targeted formulations for different life stages and health priorities. E-commerce and pet specialty retail also improve product accessibility and provide opportunities for consumer education. Innovation in ingredient research, formulation quality, and convenient product formats is expected to support continued demand for functional pet nutrition.

Region with largest share:

During the forecast period, North America is expected to hold the largest share of the Global Evidence-Based Pet Nutrition Market, supported by established pet ownership, high consumer awareness of companion animal health, and a developed veterinary care network. The United States represents a major market for premium pet food, therapeutic diets, and functional nutritional products. The presence of leading manufacturers, veterinary nutrition specialists, and established pet specialty retailers supports product availability and consumer access. In addition, widespread e-commerce adoption and demand for specialized nutrition contribute to market development. Veterinary recommendations and increasing attention to preventive healthcare further support the adoption of evidence-based nutrition across the region.

Region with highest CAGR:

Asia Pacific is expected to register the highest CAGR during the forecast period, driven by growing companion animal ownership, increasing disposable incomes, expanding urban populations, and rising awareness of specialized pet care. China, Japan, India, South Korea, and Australia provide opportunities for premium pet food, veterinary diets, and functional nutritional products. The expansion of veterinary services and pet specialty retail is improving access to specialized nutrition, while e-commerce platforms enable consumers to explore a broader range of products. Increasing interest in preventive animal healthcare and premium pet food is also encouraging manufacturers to strengthen their regional presence and develop products suited to local consumer preferences.

Key players in the market

Some of the key players in the Global Evidence-Based Pet Nutrition Market include Nestle Purina PetCare, Hill's Pet Nutrition, Inc., Mars Petcare, Royal Canin, Blue Buffalo (General Mills, Inc.), Farmina Pet Foods, Virbac, Dechra Pharmaceuticals PLC, ADM, and The Honest Kitchen.

Key Developments:

In August 2026, Nestle Purina Pro Plan Veterinary Supplements launched the FortiFlora Diarrhea Response Kit, a two-step product combining a short-term response formulation with a daily probiotic supplement to support dogs and cats experiencing occasional diarrhea. The launch expands the company's digestive health offering and strengthens its portfolio of targeted nutritional support products.

In July 2026, Royal Canin launched its first fresh, fully cooked therapeutic diet portfolio for dogs in the United States. Available exclusively through veterinarians, the Fresh Veterinary Diets range addresses specific nutritional needs, including gastrointestinal conditions, food sensitivities, and reduced appetite.

In June 2026, Hill's Pet Nutrition introduced Science Diet Single Protein Dog Food Rolls, marking its entry into the refrigerated fresh dog food category. The complete and balanced recipes were developed to support digestive health, skin and coat condition, and overall wellness, extending the company's science-led nutrition portfolio into a new product format.

In April 2026, Nestle Purina Pro Plan launched the AdvantEDGE line for adult and senior dogs and cats. The range includes digestive support formulations combining prebiotics, probiotics, and postbiotics, alongside senior-focused nutrition designed to address multiple aspects of pet well-being.

Product Types Covered:

• Therapeutic and Prescription Diets
• Life-Stage and Breed-Specific Nutrition
• Functional Foods and Supplements
• Standard Complete Nutrition

Pet Types Covered:

• Dogs
• Cats
• Other Companion Animals

Health Focus Areas Covered:

• Digestive Health
• Renal and Urinary Health
• Weight Management
• Joint Health
• Skin and Allergy Support

Distribution Channels Covered:

• Veterinary Clinics
• Pet Specialty Retail
• Online Retail
• Other Retail Channels

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
    • Saudi Arabia
    • United Arab Emirates
    • Qatar
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Egypt
    • Morocco
    • Rest of Africa

What our report offers:

• Market share assessments for regional and country-level segments
• Strategic recommendations for new entrants
• Covers market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032, and 2034
• Market trends, including drivers, constraints, opportunities, threats, challenges, investment opportunities, and recommendations
• Strategic recommendations for key business segments based on market estimations
• Competitive landscape mapping and assessment of key industry trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends and assessment of the latest technological advancements

Free Customization Offerings:

All customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, forecasts, and CAGR of any prominent country as per the client's interest (subject to feasibility assessment)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances